Posted Date: Jun 6, 2003
Plasma cell neoplasms are diseases in which certain cells in the blood (called plasma cells) become cancer. Plasma cells are made by white blood cells called lymphocytes. The plasma cells make antibodies, which fight infection and other harmful things in the body. When these cells become cancer, they may make too many antibodies and a substance called M-protein is found in the blood and urine.
There are several types of plasma cell neoplasms. The most common type is called multiple myeloma. In multiple myeloma, cancerous plasma cells are found in the bone marrow. The bone marrow is the spongy tissue inside the large bones in the body. The bone marrow makes red blood cells (which carry oxygen and other materials to all tissues of the body), white blood cells (which fight infection), and platelets (which make the blood clot). The cancer cells can crowd out normal blood cells, causing anemia (too few red blood cells). The plasma cells also may cause the bone to break down. The plasma cells can collect in the bone to make small tumors called plasmacytomas.
Plasma cell neoplasms also can appear only as growths of plasma cells (plasmacytomas) in the bone and soft tissues, without cancer cells in the bone marrow or blood.
Macroglobulinemia is a type of plasma cell neoplasm in which lymphocytes that make an M-protein build up in the blood. Lymph nodes and the liver and spleen may be swollen.
If there are symptoms, a doctor will order blood and urine tests. If the tests are not normal, the doctor may do a bone marrow biopsy. During this test, a needle is inserted into a bone and a small amount of bone marrow is taken out and looked at under the microscope. The doctor can then tell what kind of cancer the patient has and plan the best treatment. X-rays also may be done to see whether the bones are affected.
The chance of recovery (prognosis) depends on the kind of plasma cell neoplasm, and the patient's age and general health.
Once plasma cell neoplasm has been found, more tests will be done to see how far the cancer has spread. This is called staging. Plasma cell neoplasms are grouped together depending on the type of plasma cell cancer that is found. The following stages are used for multiple myeloma:
Relatively few cancer cells have spread throughout the body. The number of red blood cells and the amount of calcium in the blood are normal. No tumors (plasmacytomas) are found in the bone. The amount of M-protein in the blood or urine is very low. There may be no symptoms of disease.
A moderate number of cancer cells have spread throughout the body.
The following groups are used to determine the treatment of plasma cell neoplasms that don't involve the bone marrow.
Only a single plasma cell tumor is found in the bone without any other evidence of cancer. Patients may develop multiple myeloma at a later time.
Plasma cell tumors are found only outside the bone and the bone marrow in the soft tissues, usually the tonsils or tissues around the nose. Patients may develop multiple myeloma at a later time.
Plasma cells that produce a certain type of M-protein are found in the blood. Patients usually have swollen lymph nodes and spleen or liver.
M-protein is found in the blood without symptoms or other signs of cancer. People with this condition may develop plasma cell neoplasms or cancer of the lymph system (lymphoma) at a later time.
The plasma cells do not decrease even though treatment is given.
Surgery may be used in certain cases.
Chemotherapy uses drugs to kill cancer cells. Chemotherapy may be taken by pill, or it may be put into the body by a needle in the vein or muscle. Chemotherapy is called a systemic treatment because the drug enters the bloodstream, travels through the body, and can kill cancer cells throughout the body.
Radiation therapy uses x-rays or other high-energy rays to kill cancer cells and shrink tumors. Radiation for plasma cell neoplasms usually comes from a machine outside the body (external radiation therapy).
Biological therapy tries to get the body to fight cancer. It uses materials made by the body or made in a laboratory to boost, direct, or restore the body's natural defenses against disease. Biological therapy is sometimes called biological response modifier (BRM) therapy or immunotherapy.
Bone marrow transplantation is used to replace the bone marrow with healthy bone marrow. First, all of the bone marrow in the body is destroyed with high doses of chemotherapy with or without radiation therapy. Healthy marrow is then taken from another person (a donor) whose tissue is the same as or almost the same as the patient's. The donor may be a twin (the best match), a brother or sister, or an unrelated person. The healthy marrow from the donor is given to the patient through a needle in the vein to replace the marrow that was destroyed. A bone marrow transplant using marrow from a relative or unrelated person is called an allogeneic bone marrow transplant.
Another type of bone marrow transplant, called autologous bone marrow transplant, is being studied in clinical trials. To do this type of transplant, bone marrow is taken from the patient and treated with drugs to kill any cancer cells. The marrow is then frozen to save it. Next, the patient is given high-dose chemotherapy with or without radiation therapy to destroy all of the remaining marrow. The frozen marrow that was saved is then thawed and given back to the patient through a needle in a vein to replace the marrow that was destroyed.
Another type of autologous transplant is called a peripheral blood stem cell transplant. The patient's blood is passed through a machine that removes the stem cells (immature cells from which all blood cells develop). The machine then returns the blood back to the patient. This procedure is called leukapheresis and usually takes 3 or 4 hours to complete. The stem cells are treated with drugs to kill any cancer cells and then frozen until they are transplanted back to the patient. This procedure may be done alone or with an autologous bone marrow transplant.
A greater chance for recovery occurs if a doctor chooses a hospital which does more than five bone marrow transplantations per year.
If the spleen is swollen, the doctor may take out the spleen in an operation called a splenectomy.
If too many M-proteins build up in the blood, the patient's blood may need to be filtered through a special machine. This is called plasmapheresis.
Treatment of plasma cell neoplasms depends on the type and stage of the disease, and the patient's age and overall health.
Standard treatment may be considered because of its effectiveness in patients in past studies, or participation in a clinical trial may be considered. Not all patients are cured with standard therapy and some standard treatments may have more side effects than are desired. For these reasons, clinical trials are designed to find better ways to treat cancer patients and are based on the most up-to-date information. Clinical trials are ongoing in most parts of the country for most stages of plasma cell neoplasms. To learn more about clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237); TTY at 1-800-332-8615.
If there are no symptoms, treatment may not be needed. A doctor will follow the patient closely so treatment can be started if symptoms develop. If there are symptoms, treatment will probably be chemotherapy. Clinical trials are testing new chemotherapy drugs and dose regimens.
Treatment will probably be external radiation therapy to the tumor. If other symptoms appear, patients may receive chemotherapy.
If there are no symptoms, treatment may not be needed. A doctor will follow the patient closely so treatment can be started if symptoms develop. If there are symptoms, treatment may be chemotherapy, biologic therapy, or immunotherapy. Clinical trials are testing new chemotherapy drugs and combinations of drugs with or without stem cell support or transplant.
A doctor will follow the patient closely to see if symptoms of plasma cell neoplasm or lymphoma develop.
Treatment will probably be chemotherapy. Clinical trials are testing new drugs and combinations of drugs.
The PDQ® cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Editorial changes were made to this summary.
For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 9:00 a.m. to 4:30 p.m. Deaf and hard-of-hearing callers with TTY equipment may call 1-800-332-8615. The call is free and a trained Cancer Information Specialist is available to answer your questions.
Web sites and Organizations
The NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support and resources for cancer patients and their families. There are also many other places where people can get materials and information about cancer treatment and services. Local hospitals may have information on local and regional agencies that offer information about finances, getting to and from treatment, receiving care at home, and dealing with problems associated with cancer treatment.
The NCI has booklets and other materials for patients, health professionals, and the public. These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials. Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities. NCI materials on these and other topics may be ordered online or printed directly from the NCI Publications Locator. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237), TTY at 1-800-332-8615.
The NCI's LiveHelp service, a program available on several of the Institute's Web sites, provides Internet users with the ability to chat online with an Information Specialist. The service is available from 9:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer.
PDQ® is a comprehensive cancer database available on NCI's Web site.
PDQ® is the National Cancer Institute's (NCI's) comprehensive cancer information database. Most of the information contained in PDQ® is available online at NCI's Web site. PDQ® is provided as a service of the NCI. The NCI is part of the National Institutes of Health, the federal government's focal point for biomedical research.
PDQ® contains cancer information summaries.
The PDQ® database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries are available in two versions. The health professional versions provide detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions provide current and accurate cancer information.
The PDQ® cancer information summaries are developed by cancer experts and reviewed regularly.
Editorial Boards made up of experts in oncology and related specialties are responsible for writing and maintaining the cancer information summaries. The summaries are reviewed regularly and changes are made as new information becomes available. The date on each summary ("Date Last Modified") indicates the time of the most recent change.
PDQ® also contains information on clinical trials.
Before starting treatment, patients may want to think about taking part in a clinical trial. A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about new treatments, the risks involved, and how well they do or do not work. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard."
Listings of clinical trials are included in PDQ® and are available online at NCI's Web site. Descriptions of the trials are available in health professional and patient versions. Many cancer doctors who take part in clinical trials are also listed in PDQ®. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237); TTY at 1-800-332-8615.
Jan 31, 2013 - Early palliative care clinic visits, integrated with standard oncologic care for patients with metastatic lung cancer, emphasize symptom management, coping, and psychosocial aspects of illness, according to research published online Jan. 28 in JAMA Internal Medicine.
Feb 27, 2015
Apr 30, 2012